Meanwhile, independent clinical-pathologic studies show PD-L1 can be expressed by CAFs and that CAFs upregulate PD-L1 in tumor cells via AKT phosphorylation, reinforcing the idea that stromal programs help enforce immune suppression. Here, AKT1 is linked to neoplasm.